Chapter 44 Care of Patients with Problems of the Central Nervous System
The Brain
Safe and Effective Care Environment
1. Plan health teaching for hospital discharge to home or other setting for patients with chronic problems of the brain.
2. Collaborate with interdisciplinary health care team members when caring for older adults with Parkinson disease (PD) and Alzheimer’s disease (AD).
3. Implement interventions to protect patients with AD, PD, and seizures from injury.
Health Promotion and Maintenance
4. Teach patients with chronic headaches about complementary and alternative therapies.
5. Teach patients in highly populated areas ways to prevent meningitis.
6. Teach patients and their families about credible resources for genetic testing and counseling for types of chronic brain disorders that are known to be hereditary.
7. Identify community resources for patients with PD and AD.
8. Include the family when culturally appropriate in developing the plan of care for patients with chronic brain disorders.
9. Identify ways to help prevent caregiver stress when caring for patients with AD and other chronic neurodegenerative diseases.
10. Adapt communication techniques for patients with dementia, including validation therapy.
11. Identify triggers for patients with chronic headaches.
12. Compare the assessment findings of migraine, cluster, and tension headaches.
13. Prioritize care for patients with migraine headaches.
14. Differentiate the common types of seizures, including presenting clinical manifestations.
15. Prioritize care for patients experiencing acute seizures and status epilepticus.
16. Describe collaborative care for a patient having a seizure.
17. Implement seizure precautions for patients at risk for acute seizures or status epilepticus.
18. Identify nursing priorities for patients with bacterial meningitis and encephalitis.
19. Describe abnormal neurologic findings in patients with chronic brain problems.
20. Identify the genetic and environmental influences on development of PD, AD, and Huntington disease.
21. Develop a community-based plan of care for a patient with PD and AD.
22. Provide health teaching for patients and family about drug therapy for patients with chronic brain problems.
23. Develop a collaborative plan of care for patients with AD.
24. Prevent or reduce common risk factors that contribute to functional decline and decreased quality of life in older adults with PD and AD.
25. Develop a teaching plan for caregivers of patients with AD.
26. Identify the need for genetic counseling for patients who have Huntington disease.
http://evolve.elsevier.com/Iggy/
Animation: Functional Areas of the Brain
Answer Key for NCLEX Examination Challenges and Decision-Making Challenges
Review Questions for the NCLEX® Examination
Headaches
As part of the nursing assessment, ask patients about the pattern of their headaches. For example:
• When do the headaches occur?
• Do certain foods, alcohol, or other things trigger the headaches?
• Have there been any recent changes in your headaches?
• How do you treat the headaches? Does this treatment work?
• Is there a family history of headaches?
• Where do the headaches begin? Do they spread to other areas?
• Do you experience other symptoms with the headaches, such as weakness or changes in speech?
Action Alert
Migraine Headache
Pathophysiology
A migraine headache is a chronic, episodic disorder with multiple subtypes. It is characterized by an intense pain in one side of the head (unilateral) worsening with movement and occurs with either photophobia (sensitive to light) or phonophobia (sensitive to noise). Either moderate to severe nausea or vomiting is also present (McCance et al., 2010). A migraine is classified as a long-duration headache because it usually lasts 4 to 72 hours.
Migraines tend to be familial, and women are affected more commonly than men. Women with anxiety and depressive personalities are particularly predisposed to migraines and other chronic health problems (Tan et al., 2007). Migraine sufferers are also at risk for stroke and epilepsy (McCance et al., 2010).
The cause of migraine headaches is likely a combination of vascular, genetic, neurologic, hormonal, and environmental factors. It is generally agreed that migraine headaches are mediated via the trigeminal vascular system and its central projections. Blood vessels in the brain overreact to a triggering event, causing spasm in the arteries at the base of the brain. This response is followed by arterial constriction and a decrease in cerebral blood flow. Cerebral hypoxia may occur. Platelets clump together, and serotonin, a vasoconstrictor, is released. Other arteries dilate, which triggers the release of prostaglandins (chemicals that cause inflammation and swelling) and other substances that increase sensitivity to pain. Research suggests a role of excessive synaptic glutamate release or decreased removal of glutamate and potassium from the synaptic cleft (Sanchez-del-Rio et al., 2006).
Patient-Centered Collaborative Care
Assessment
Migraines fall into three categories: migraines with aura, migraines without aura, and atypical migraines. An aura is a sensation such as visual changes that signals the onset of a headache or seizure. In a migraine, the aura occurs immediately before the migraine episode. Most headaches are migraines without aura. The key features of migraines are listed in Chart 44-1. Atypical migraines are less common and include menstrual and cluster migraines. The stages of migraine may include:
• Prodrome (or prodromal) phase, in which the patient has specific symptoms such as food cravings or mood changes
• Aura phase (if present), which generally involves visual changes, flashing lights, or diplopia (double vision)
• Headache phase, which may last a few hours to a few days
• Termination phase, in which the intensity of the headache decreases
• Postprodrome phase, in which the patient is often fatigued, may be irritable, and has muscle pain
Migraine Headaches
Phases of Migraine with Aura (Classic Migraine)
First, or Prodrome, Phase
Migraine Without Aura (Common Migraine)
• Migraine begins without an aura before the onset of the headache.
• Pain is aggravated by performing routine physical activities.
• Pain is unilateral and pulsating.
• One of these symptoms is present:
• Headache lasts for 4 to 72 hours.
• Migraine often occurs in the early morning, during periods of stress, or in those with premenstrual tension or fluid retention.
Some physicians recommend screening migraine patients with the Minnesota Multiphasic Personality Inventory–2 to identify personality traits and possible mental health/behavioral health problems (Tan et al., 2007). Neuroimaging such as magnetic resonance imaging (MRI) may be indicated if the patient has other neurologic findings, a history of seizures, findings not consistent with a migraine, or a change in the severity of the symptoms or frequency of the attacks.
Neuroimaging is also recommended in patients older than 50 years with a new onset of headaches, especially women. Women with a history of migraines with visual symptoms may have an increased risk for stroke (McCance et al., 2010). This risk increases if a migraine with visual symptoms occurred in the past year. Teach women older than 50 years who have migraines about the risk factors for cardiovascular disease. Encourage them to notify their health care provider if they experience symptoms such as facial drooping, arm weakness, or difficulties with speech.
Interventions
Migraine headaches are often not diagnosed or managed following current best practices. Therefore the National Headache Foundation has recommended the “Three R” approach for patients and health care providers (www.headaches.org):
Abortive Therapy
Abortive therapy is aimed at alleviating pain during the aura phase (if present) or soon after the headache has started. Drug therapy is prescribed to manage migraine headaches. Some of the drugs being used have major side effects, contraindications, and nursing implications. The health care provider must consider any other medical conditions that the patient has when prescribing drug therapy. In general, the patient is started on a low dose that is increased until the desired clinical effect is obtained. Table 44-1 lists commonly used drugs for migraine headaches. Many new drugs are being investigated for this painful and often debilitating health problem.
Nonspecific Analgesics |
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
Ergotamine Preparations |
Beta Blockers |
Triptan Preparations |
Isometheptene Combination |
Antiepileptic Drugs (AEDs) |
Drug Alert
Preventive Therapy
Drug Alert
In addition to drug therapy, trigger avoidance and management are important interventions for preventing migraine episodes. For example, some patients find that avoiding tyramine-containing products, such as pickled products, caffeine, beer, wine, preservatives, and artificial sweeteners, reduces their headaches. Others have identified specific factors that trigger an attack for them. Help patients identify triggers that could cause migraine episodes, and teach them to avoid them once identified (Chart 44-2). For example, at the beginning of a migraine attack, the patient may be able to reduce pain by lying down and darkening the room. He or she may want both eyes covered and a cool cloth on the forehead. If the patient falls asleep, he or she should remain undisturbed until awakening.
Chart 44-2 Patient and Family Education
Preparing For Self-Management: Factors That May Trigger a Migraine Attack
Complementary and Alternative Therapies
Physiological Integrity
A. “Take this drug only when you have symptoms at the beginning of a migraine headache.”
B. “This drug is low dose, so you don’t have to worry about your heart rate or blood pressure.”
C. “This drug will relieve the pain during the aura phase soon after a headache has started.”
D. “Take this drug as prescribed every day, even when feeling well, to prevent a migraine.”
Cluster Headache
Pathophysiology
Cluster headaches are manifested by brief (30 minutes to 2 hours), intense unilateral pain that generally occurs in the spring and fall without warning. It is classified as the most common chronic short-duration headache with pain lasting less than 4 hours. Also referred to as trigeminal autonomic cephalalgia, it is far less common than migraines. Cluster headaches typically develop in men between 20 and 50 years of age. The cause and mechanism of cluster headaches are not known but have been attributed to vasoreactivity and neurogenic inflammation (McCance et al., 2010). Neuroimaging studies suggest that cluster headaches are related to an overactive and enlarged hypothalamus.
Patient-Centered Collaborative Care
Assessment
The headache usually occurs with:
Interventions
During the periods of attack, teach the patient to wear sunglasses and to sit facing away from the window to help decrease exposure to light and glare. If the health care provider prescribes oxygen, 100% oxygen via mask at 7 to 10 L/min is typically administered with the patient in a sitting position. Administer the oxygen for 15 to 30 minutes, and discontinue it when the headache is relieved. Oxygen reduces cerebral blood flow and inhibits activity of the carotid bodies, which are sensitive to oxygen levels in the body. Patients may use oxygen at home. Teach them about the precautions that must be taken when oxygen is used (see Chapter 30).
Surgical intervention may be recommended for patients with chronic drug-resistant cluster headaches. Invasive ambulatory care procedures, such as percutaneous stereotactic rhizotomy (PSR), are performed with varying success rates. Information about this procedure is found in Chapter 46 in the Trigeminal Neuralgia section. Long-term high-frequency electrical stimulation of the posterior hypothalamus, also known as deep brain stimulation, may reduce or eliminate pain (see discussion on p. 946 in the Parkinson Disease section). It has not been approved by the FDA but is being investigated. Both of these procedures have major complications that can cause permanent brain or nerve damage. Therefore they are done as a last resort.
Seizures and Epilepsy
Pathophysiology
Epilepsy is defined by the National Institute of Neurological Disorders and Stroke as two or more seizures experienced by a person. It is a chronic disorder in which repeated unprovoked seizure activity occurs. It may be caused by an abnormality in electrical neuronal activity; an imbalance of neurotransmitters, especially gamma aminobutyric acid (GABA); or a combination of both (McCance et al., 2010).
Types of Seizures
Considerations for Older Adults
Complex partial seizures are most common among older adults (Vacca & Olson, 2007). These seizures are difficult to diagnose because symptoms appear similar to dementia, psychosis, or Alzheimer’s disease (AD), especially in the postictal stage (after the seizure). New-onset seizures in older adults are typically associated with conditions such as hypertension, cardiac disease, diabetes mellitus, stroke, and Alzheimer’s disease.
Etiology and Genetic Risk
Patient-Centered Collaborative Care
Assessment
Diagnosis is based on the history and physical examination. A variety of diagnostic tests are performed to rule out other causes of seizure activity and to confirm the diagnosis of epilepsy. Typical diagnostic tests include an electroencephalogram (EEG), computed tomography (CT) scan, MRI, or positron emission tomography (PET) scan. These tests are described in Chapter 43. Laboratory studies are performed to identify metabolic or other disorders that may cause or contribute to seizure activity.
Nonsurgical Management
Drug Therapy.
Drug therapy is the major component of management (Chart 44-3). The health care provider introduces one antiepileptic drug (AED) at a time to achieve seizure control. If the chosen drug is not effective, the dosage may be increased or another drug introduced. At times, seizure control is achieved only through a combination of drugs. The dosages are adjusted to achieve therapeutic blood levels without causing major side effects.
Chart 44-3 Common Examples of Drug Therapy
Antiepileptic Drugs
DRUG | INDICATION FOR USE | NURSING INTERVENTIONS |
---|---|---|
Carbamazepine (Tegretol, Tegretol-XR, Carbatrol) | Partial, generalized tonic-clonic seizures | |
Clonazepam (Klonopin) | Absence, myoclonic, and akinetic seizures | |
Clorazepate dipotassium | Adjunctive management of partial seizures | |
Diazepam (Valium, Apo- Diazepam ), lorazepam (Ativan), Diastat (diazepam rectal gel delivery system) | Status epilepticus | |
Divalproex (Depakote), valproic acid (Depakene) | All types of seizures | |
Ethosuximide (Zarontin) | Absence seizures | |
Felbamate (Felbatol) | Adjunctive therapy for intractable complex partial seizures | |
Gabapentin (Neurontin) | Partial seizures | |
Lamotrigine (Lamictal) | Partial seizures | |
Levetiracetam (Keppra) | Adjunct management of partial seizures | |
Oxcarbazepine (Trileptal) | Partial seizures | |
Phenobarbital (Barbita, Luminal) | Generalized tonic-clonic seizures, partial seizures | |
Phenytoin (Dilantin), fosphenytoin (Cerebyx) | All types, except absence, myoclonic, and atonic seizures; for status epilepticus | |
Primidone (Mysoline, Sertan ) | Partial seizures, generalized tonic-clonic seizures | |
Tiagabine (Gabitril) | Partial seizures | |
Topiramate (Topamax) | Adjunctive therapy for intractable partial seizures | |
Valproate (Depakote), valproate sodium injection (Depacon) | Simple and complex absence seizures Adjunct therapy for partial complex and generalized tonic-clonic seizures | |
Zonisamide (Zonegran) | Adjunctive therapy for partial seizures |
Considerations for Older Adults
The health care provider prescribes AEDs for the older adult that (Vacca & Olson, 2007):
• Have minimal possibility of toxicity
• Are available in oral route for dosing
• Are easily metabolized and absorbed
• Have a long half-life with infrequent dosing to prevent missed dose
• Require minimal protein binding, because older adults lose protein and a therapeutic dose may be toxic to them
• Cause minimal to no weight gain to prevent complications that may be associated with heart disease
Teaching for Self-Management.
Provide an educational program for the patient and family (Chart 44-4). Ask them what they understand about the disorder, and correct any misinformation. As new information is presented, be sure that the patient and family can understand it. Refer patients and families to the Epilepsy Foundation of America (www.epilepsyfoundation.org) for more information and community support groups.
Chart 44-4 Patient and Family Education
Preparing for Self-Management: Health Teaching for the Patient with Epilepsy
• Do not take any medication, including over-the-counter drugs, without asking your health care provider.
• Wear a medical alert bracelet or necklace, or carry an ID card indicating epilepsy.
• Follow up with your neurologist, physician, or other health care provider as directed.
• Be sure a family member or significant other knows how to help you in the event of a seizure and knows when your health care provider or emergency medical services should be called.
• Investigate and follow state laws concerning driving and operating machinery.
• Avoid alcohol and excessive fatigue.
• Contact the Epilepsy Foundation (www.epilepsyfoundation.org) or other organized epilepsy group for additional information. Epilepsy Canada (www.epilepsy.ca) also provides resources and support.
Seizure Management.
The actions taken during a seizure should be appropriate for the type of seizure (Chart 44-5). For example, for a simple partial seizure, observe the patient and document the time that the seizure lasted. Redirect the patient’s attention away from an activity that could cause injury. Turn the patient on the side during a generalized tonic-clonic or complex partial seizure because he or she may lose consciousness. If possible, turn the patient’s head to the side to prevent aspiration and allow secretions to drain. Remove any objects that might injure the patient.
Chart 44-5 Best Practice for Patient Safety & Quality Care
Care of the Patient During a Tonic-Clonic or Complete Partial Seizure
• Protect the patient from injury.
• Do not force anything into the patient’s mouth.
• Turn the patient to the side to keep the airway clear.
• Loosen any restrictive clothing the patient is wearing.
• Maintain the patient’s airway and suction as needed.
• Do not restrain or try to stop the patient’s movement; guide movements if necessary.
• Record the time the seizure began and ended.
• At the completion of the seizure:
It is not unusual for the patient to become cyanotic during a generalized tonic-clonic seizure. The cyanosis is generally self-limiting, and no treatment is needed. Some health care providers prefer to give the high-risk patient (e.g., older adult, critically ill, or debilitated patient) oxygen by nasal cannula or facemask during the postictal phase. He or she is not restrained because this may cause injury and may worsen the situation, causing more seizure activity. For any type of seizure, carefully observe the seizure and document assessment findings (Chart 44-6).
Seizures: Nursing Observations and Documentation
• How often the seizures occur:
• Description of each seizure:
• Whether more than one type of seizure occurs
• Sequence of seizure progression:
• Observations during the seizure:
• When the last seizure took place
• Whether the seizures are preceded by an aura:
• What the patient does after the seizure:
• How long it takes for the patient to return to pre-seizure status
Emergency Care: Acute Seizure and Status Epilepticus Management.
Critical Rescue
Serum drug levels are checked every 6 to 12 hours after the loading dose and then 2 weeks after oral phenytoin has started. Teach the patient about the side and adverse effects of any AED that is prescribed (see Chart 44-3).
Safe and Effective Care Environment
Surgical Management
Conventional Surgical Procedures.
Preoperative care is similar to that described for patients undergoing a craniotomy (see Chapter 47). Preoperative diagnostic tests include MRI and single-photon emission computed tomography (SPECT)/positron emission tomography (PET) scans as described in Chapter 43. An intracarotid amobarbital test (Wada test) and neuropsychological testing are also done. The Wada test assesses hemispheric lateralization of language and memory after injection of amobarbital, a short-acting anesthetic. This procedure establishes the safety of surgery to preserve language memory. Neuropsychological testing evaluates memory, visuospatial function, language function, and intelligence quotient (IQ) to identify deficiencies in the brain that might correspond to areas believed to be the epileptic region. It is also used to compare preoperative and postoperative cognitive functioning.